Lonza Group, CH0013841017

Lonza Group stock heads into the open after a modest SMI underperformance

Published on 09/17/2026 at 07:48 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

At the close on September 16, 2026, Lonza Group stock eased slightly on SIX Swiss Exchange while the SMI ended the session higher. The stock traded within a relatively tight intraday range as investors digested recent expansion news in the United States.

Schwarz-Weiß-Reportage: Wissenschaftler im Schutzanzug am Mikroskop, dokumentarischer Stil
Lonza CH0013841017 Forscher im Schutzanzug am Mikroskop dokumentarisch in Schwarz Weiss fotografiert, Illustration mit AI erstellt.

Lonza Group stock closed at CHF 537.80 on SIX Swiss Exchange on September 16, 2026, down 0.1% from the prior session. On the same day, the Swiss Market Index finished higher, leaving Lonza Group trailing the broader Swiss benchmark by a small margin per exchange data.

September 16, 2026 in numbers

Lonza Group Inc. (ISIN CH0013841017) saw its shares move in a narrow band around the CHF 538 mark on September 16, 2026, with the closing price at CHF 537.80 on SIX Swiss Exchange and only a slight percent decline on the day. The modest slip contrasted with gains in several SMI constituents, as the index was reported in positive territory during the session while Lonza Group added only 0.11% at one intraday reading before finishing marginally lower, according to a market overview from finanzen.ch. The session left the stock close to its recent trading levels, with no sharp move against its short-term range.

Expansion news shapes today

Today, the market continues to process Lonza Group expansion headlines from the United States. The company recently broke ground on a new commercial spray-drying pharmaceutical manufacturing facility in Bend, Oregon, following an investment announcement earlier in September, as reported by Construction Review Online. In addition, Lonza Group outlined its strategic focus on contract development and manufacturing, growth, and cash generation at the Morgan Stanley 24th Annual Global Healthcare Conference on September 15, 2026, providing investors with updated messaging on portfolio transition and investment priorities, according to Investing.com. These developments, together with the broader Swiss equity backdrop, are key reference points for Lonza Group stock as trading is set to begin on SIX Swiss Exchange today.

Disclaimer...

en | CH0013841017 | LONZA GROUP | boerse | 70115279 | bgmi